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Abstract
Background: Dyslipidemia is a multifactorial disorder, which arises from complex interactions among genetic and
environmental risk factors. Previous studies have established the deteriorating effect of aging on lipid profiles.
However, little is known about the role of education level, a stable marker of socioeconomic status, which reflect
modifiability of lifestyle risk factors. Therefore, we examined the association between age and individual
dyslipidemia parameter across education level among healthy, middle-aged Korean women.
Methods: From 2049 middle-aged women, education attainment was classified into completion of elementary
school or below, middle school, high school, college or above. Dyslipidemia was assessed in adherence to the 2018
Korean Dyslipidemia Treatment Guideline. Multivariable logistic regression and generalized linear model tested for
associations between age and dyslipidemia parameter across education level and other known risk factors,
including menopause, obesity, and current drinking and smoking.
Results: In this cross-sectional analysis, the prevalence of each dyslipidemia parameter was significantly different by
age and education level. The odds ratio (OR) for dyslipidemia was higher among participants who were older and
had received higher education (OR = 2.31, p for interaction = 0.008) than younger and low education counterpart.
The interaction between age and education level remained significant for hypercholesterolemia (p for interaction =
0.003) and hyper-LDL-cholesterolemia (p for interaction = 0.002).
Conclusions: Separate examination of individual dyslipidemia parameter indicated varying degree of interaction
with age and education level. Such results imply that each type of lipid abnormality may arise from and be
exacerbated by heterogeneous composition of biological and lifestyle risk factors, which may be reflected by
education level.
Keywords: Dyslipidemias, Aging, Education, Risk factors
Introduction
Dyslipidemia is a multi-etiologic and polygenic disorder
that arises from complex interactions among genetic, en-
vironmental, behavioral, and social risk factors [1, 2]. Previ-
ous studies have established that adverse lipid levels
independently contribute to development and progression
of atherosclerotic cardiovascular and coronary heart dis-
eases (ASCVD and CHD) [3–5]. Lipid abnormality is par-
ticularly concerning in women, as they undergo drastic
escalation with biological aging and menopause-related
endocrine changes, triumphing those of men by the fifth
decade [6]. In 2017, the Global Burden of Disease study re-
ported that high concentrations of cholesterols caused
about 4.4 million deaths and 93.8 million disability-
adjusted life years, representing the seventh leading risk
factors globally for women [7, 8]. Analogously, the recent
Korean statistics pinpointed age-dependent drastic increase
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in dyslipidemia prevalence in women, mounting from
14.9% in third decade to 56.4% by the age of 60 [9].
Along with biological age, socioeconomic status (SES)
is a pronounced risk factor of dyslipidemia, that is impli-
cated with modifiable lifestyle risk factors, such as
cigarette smoking, alcohol consumption, and physical in-
activity. Moreover, SES is also associated with differen-
tial exposure to physiological and psychological stress
and material resources, including timely access to ad-
equate health care [10]. In particular, education level is
one of the most commonly utilized markers of SES that
is relatively stabilized in early periods of life, unlike in-
come or occupation. It is resistant to changes in life-
course circumstances or health [11]. It is suggested that
education enables people to integrate healthy behaviors
into a coherent lifestyle, thereby affecting health-related
choices, independent of parental, spousal, or neighbor-
hood SES status [12].
Previous literature regarding the role of education on
dyslipidemia have been inconsistent by population char-
acteristics. In a Korean study that examined association
between the SES and dyslipidemia, the risks for hypoal-
phalipoprotein and hypertriglyceridemia increased stead-
ily with decreasing household income and education
level [13]. However, in a multinational study assessing
the association of lifelong education level with subclin-
ical atherosclerosis, the results were defined in men only
[14]. With accumulated evidence suggesting the dispro-
portionate risk associated with a broad range of un-
healthy lifestyle factors manifested by education level, it
is crucial to examine the role of education on risk of
dyslipidemia.
The prevalence of individual parameter of dyslipidemia
and its association with age and education level have not
been fully investigated in Korean population. Hitherto, the
objective of this study was to describe age-specific preva-
lence rates of individual parameter of dyslipidemia among
community-dwelling middle-aged Korean women, a sex
demonstrating more heterogeneous education background.
Then, we identified whether there are significant interac-
tions observed on dyslipidemia prevalence between age
and education level. We hypothesized that the association
between age and each dyslipidemia parameter will be dif-
fered by education level in different directions and
magnitudes.
Methods
Study population
The study participants consisted of female, community-
dwelling, capital residents of Republic of Korea, who
were enrolled in the Cardiovascular and Metabolic Dis-
eases Etiology Research Center (CMERC) cohort. Briefly,
the CMERC study aimed to identify novel risk factors
and to investigate distribution and effects of known
cardiac and metabolic diseases risk factors, ultimately to
develop improved cardiovascular disease prediction tools
for the general Korean population [15]. Using validated
questionnaire, the trained interviewee collected detailed
information on SES, health behaviors, disease history,
nutrition, and psychosocial characteristics. Adhering to
standardized protocols, anthropometry and blood and
urinal profiles were also assayed to identify high-risk in-
dividuals who will merit from earlier intervention [15].
The exact details of the CMERC study has been pub-
lished elsewhere [15]. In the present study, among 3332
participants who have undergone baseline examination
between 2013 and 2017, participants with history of ma-
lignant cancer, overt cardiovascular diseases, or missing
information on lipid profiles glycemic index were ex-
cluded, yielding 2049 participants for the final analysis.
This study has been approved by the institutional re-
view boards of Severance Hospital, Yonsei University
Health System, Seoul, Korea (4–2013-0661). Written in-
formed consent has been obtained from all participants
prior to the baseline survey. Participants were ensured
that they can withdraw from the study at any time, re-
gardless of its cause.
Questionnaire survey and health examination
A face-to-face interview obtained details on the following
demographic characteristics and health-related behaviors.
Age was cross-referenced with government-issued identifi-
cation and obtained in years. Then, we divided age into
four groups: 30–39 years, 40–49 years, 50–59 years, and
60–64 years and, again, by median age of 54 years. House-
hold income was obtained in the nearest Korean won then
categorized into cohort-specific quartile. Current occupa-
tion was classified into white and blue collar or un-
employed. Education level was categorized into completion
of elementary school or below, middle-school, high school,
or college/university; it was also categorized into low (com-
pletion of high school or below) and high (college degree
or above). Physical activity was assessed by the Korean ver-
sion of the International Physical Activity Questionnaire
(IPAQ) standard [16] to yield metabolic equivalent of task
(MET). Alcohol consumption was recorded as the average
frequency and amount of intake over the past year, separ-
ately by the type of alcoholic beverage. Cigarette smoking
status was recorded as average packs per day, likewise over
the past year. Information on reproductive health included
menopausal status, defined by cessation of menstruation
for a minimum of one consecutive year, number of and
pregnancy and its successive outcomes (childbirth, miscar-
riage, abortion, and still-birth), history of gestational hyper-
tension or diabetes, and oral contraceptive/hormonal
replacement therapy usage duration. Dietary patterns were
evaluated using a semi-quantitative food frequency ques-
tionnaire, which was developed and validated for the
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general Korean population [17]. Major macro- and micro-
nutrients, such as daily caloric, carbohydrates, fat, and so-
dium intake, were calculated. Information on familial and
personal morbidity history included the age at the first
diagnosis of hypertension, diabetes mellitus, fatty liver, and
so on. Accordingly, the participants presented prescription
record entailing previous and current treatment status, in-
cluding lipid-lowering medications prescribed. The quality
of the survey was controlled by trained personnel using
calibrated equipment and strict adherence to standardized
protocols.
Anthropometric measurements and biochemical tests
Height was measured to the nearest 0.1 cm using stadi-
ometers: a DS-102 (Jenix, Seoul, Korea), and weight was
measured to the nearest 0.1 kg on a digital scale: a DB-
150 (CAS, Seongnam, Korea). To minimize measure-
ment variability, a zero-point adjustment was conducted
at least once a week using a standard ruler (170 cm) and
weights (20, 40, and 60 kg). Body mass index (BMI) was,
then, calculated as a ratio of weight in kilograms to
height in squared meters [18]. Blood pressure was mea-
sured using both single- and double-arm automated
oscillometric device (HEM-7080, Omron Health, Matsu-
saka, Japan and HEM-9000 AI, Omron Health).
Overnight-fasting blood samples and casual urine sam-
ples were obtained in the morning, and bioassays were
performed at a single laboratory (Seoul Clinical Labora-
tories R&D Center, Seoul, Korea). Serum lipid markers,
including total cholesterol (TC), triglycerides (TG), high-
density lipoprotein cholesterol (HDLC), and low-density
lipoprotein cholesterol (LDLC) levels were analyzed en-
zymatically with an ADIVA 1800 AutoAnalyzer (Sie-
mens Medical Sol.).
Definition of dyslipidemia
From eight-hours fasting serum, total cholesterol (TC),
triglycerides (TG), high-density lipoprotein cholesterol
(HDLC) and low-density lipoprotein cholesterol (LDLC)
levels were analyzed enzymatically with an ADVIA 1800
AutoAnalyzer (Siemens Medical Sol.). In this analysis,
we presented the distribution of TG in its logarithmic
form due to skewed distribution. Dyslipidemia was de-
fined based on the 2018 Korean Dyslipidemia Treatment
Guideline [19], which is equivalent to the Adult Treat-
ment Panel III guidelines [20]. Hypercholesterolemia
was defined as TC ≥240 mg/dL; hypertriglyceridemia
was defined as TG ≥200 mg/dL; hypoalphalipoproteine-
mia was defined as HDLC < 40mg/dL; hyper-LDL-
cholesterolemia was defined as LDLC ≥160 mg/dL. Hav-
ing any one type of the aforementioned cholesterol
abnormality or current intake of lipid-lowering agent
was regarded as prevalent dyslipidemia.
Statistical analyses
General characteristics of the study population were re-
ported as frequency and percentage or mean and standard
deviation. Then, they were compared via independent t-
test, the Wilcoxon rank sum test, chi-square test for dif-
ferences, or analysis of variance test for multiple compari-
sons. Prevalence of dyslipidemia and its parameter were
calculated separately by age and education level. We used
multivariable logistic regression to calculate odds ratio
(OR) and 95% confidence interval (CI) to calculate the risk
associated with older age across education level. Then, we
employed generalized linear model to identify presence of
interaction between age and education level and other
known risk factors of dyslipidemia. Here, we tested for
interaction between age (both as continuous and categor-
ical) and education (both as aforementioned four categor-
ies and binary by higher education). The final model was
adjusted for BMI, reproductive history, household income,
occupation, education level, current drinking and smoking
status, physical activity, and current intake of lipid-
lowering agents. Hosmer-Lemeshow goodness of fit for lo-
gistic regression and C-statistic ensured appropriateness
of the model. Sensitivity analyses were conducted by using
lower LDLC cutoffs in the context of secondary preven-
tion. Specifically, we referred to the 2018 Korean dyslipid-
emia guidelines [19] and the 2019 European Society of
Cardiology/European Atherosclerosis Society guidelines
for the management of dyslipidemia’s21 target LDLC
≥130mg/dL for persons with low ASCVD risk and LDLC
≥116mg/dL for moderate ASCVD risk. Those within
these elevated LDLC ranges are recommended lifestyle
modification or/and initiation/intensification of pharma-
cological treatment. All statistical tests were two-sided,
and the statistical significance was set at a p-value< 0.05.
All analyses were performed using SAS version 9.4 (SAS
Institute Inc., Cary, NC).
Results
Participant characteristics
A total of 821 out of 2049 female participants (40.1%)
had dyslipidemia (Additional file 1: Fig. S1). Table 1 pre-
sents the general characteristics of the study participants
by age group and completion of higher education. When
stratified by decile age group, the oldest group had the
lowest proportion of higher education, household in-
come, employment, current smoking and drinking, and
average caloric intake. Yet, women in their fifth decade
presented the highest TC, TG, and LDLC levels whilst
the lowest HDLC level. Generally, adverse lipid profiles
were accompanied by the highest percentage of obesity,
hypertension, and diabetes comorbidities.
Again, there were substantial differences by education at-
tainment. Women in low education group were signifi-
cantly older, had higher BMI and proportion of menopause
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yet lower average energy intake and higher physical activity
level. In terms of SES indicators, there were marked differ-
ences in distribution of household income and current oc-
cupation; low education women reported lower household
income and higher unemployment. In addition, there were
pronounced differences in health behavior; high education
women were less likely to be current smoker yet more
likely to be current drinker. Compared to their counterpart,
high education women presented significantly lower TC
(196.9 vs. 200.6mg/dL), log(TG) (4.5 vs. 4.7), and LDLC
(114.8 vs. 116.8mg/dL) yet and higher HDLC (61.9 vs.
60.4mg/dL) levels.
Prevalence of dyslipidemia
As illustrated in Fig. 1 and Table 2, the prevalence of
dyslipidemia incrementally increases from the youngest
group (22.5% in low education group; 9.0% in high edu-
cation group) to the oldest group (61.4 and 60.6%, re-
spectively). In all age groups, high education group had
comparatively lower prevalence of dyslipidemia than the
low education group.
However, when examining individual parameter of dys-
lipidemia, the age-associated trend was largely divergent
by education level (Table 2 and Figs. 2). Regardless of edu-
cation level, the prevalence of hypercholesterolemia accli-
mated to its zenith in 50–59 years group, then declined in
the oldest group. Moreover, until the fifth decade, hyper-
cholesterolemia was more common in low education
group; however, its prevalence was triumphed by that of
high education group after the age 50. The prevalence of
hypertriglyceridemia and hypoalphaliproteinemia was
consistently higher in low education group within all age
groups. Interestingly, women in fourth decade had lower
prevalence of hypercholesterolemia than those in third
decade in both low (11.8% vs. 15.8%) and high (14.9% vs.
18.6%) education groups. Lastly, whereas the prevalence
of hyper-LDL-cholesterolemia was incrementally higher
with older age in high education level group, its low edu-
cation counterpart showed reduction from the age 50–59
years (10.4%) to 60–64 years group (5.7%). Separate exam-
ination of each cholesterol and triglyceride levels indicated
parallel results (Additional file 1: Table S1).
Interaction between age and education level on
dyslipidemia prevalence
We used multivariable logistic regression to calculate
odds ratio (OR) and 95% confidence interval (CI) associ-
ated with older age across education level. Then, we
employed generalized linear model to identify presence
of interaction between age and education level and other
known risk factors of dyslipidemia. Here, we tested for
interaction between age (both as continuous and cat-
egorical) and education (both as ordinal and binary).
Overall, older age was associated higher risk for dyslip-
idemia yet without reaching statistical significance (OR =
1.06, 95% CI = 0.80–1.41) (Additional file 1: Table S2).
However, individual parameter of dyslipidemia showed
varying levels of risk associated with older age (Additional
file 1: Table S3). Furthermore, there was a significant
interaction between age and education level on dyslipid-
emia (p for interaction = 0.008), which was maintained in
separate examination of hypercholesterolemia (p for
Fig. 1 Prevalence of dyslipidemia by age group and education level (n = 2049). Low education level refers to completion of high school or
below; high education level refers to completion of college or above
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interaction = 0.003) and hyper-LDL-cholesterolemia (p for
interaction = 0.002) (Fig. 3). Sensitivity analyses based on
secondary prevention levels indicated attenuated associa-
tions yet in parallel directions (Additional file 1: Table S4).
Additionally, other ASCVD risk factors also modified age-
cholesterol associations; there significant age by current
smoking interactions on hypercholesterolemia (p for inter-
action = 0.018) and age by current drinking interactions on
hypertriglyceridemia (p for interaction = 0.019) (Additional
file 1: Table S3).
Discussion
Our findings extend the conventional assay of dyslipid-
emia prevalence by illustrating the degree of effect modifi-
cation that education level exerts on the association
between age and dyslipidemia parameter, independent of
other SES, behavioral, and reproductive risk factors. Over-
all, all dyslipidemia parameter worsened with older age,
yet in non-linear manner. Furthermore, the degree of such
deterioration differed by education level; notably, educa-
tion level exerted a significant interaction on dyslipidemia,
as a whole, and on its TC and LDLC components.
Such discrepancy is clinically concerning, especially in
women, considering that there are substantial differences
in CHD treatment and target lipid achievement by sex,
age, and SES. A multinational study [21, 22] conducted by
the European Society of Cardiology has reported worse
cardiovascular risk profile in females across all age groups,
with a significant sex by sex and education interaction
[21]. Specifically, males were more likely non-obese, be
equipped with smoking cessation aid, and to perform suf-
ficient physical activity, thereby more likely to attain target
LDLC and glycated hemoglobin levels. The subgroup ana-
lyses pinpointed the largest sex difference in less educated
and elderly patients [22].Furthermore, this discriminative
role of education in ASCVD risk factor control was more
highlighted in women, where compliance with recommen-
dations on lifestyle changes in patients with established
CHD was inversely associated to SES in both primary and
secondary prevention contexts [22].
Older age has historically been established as the most
devastating contributor of dyslipidemia. Both cross-
sectional and longitudinal studies have shown that TC,
LDLC, and TG concentrations were positively associated
with age, whilst a significant negative association with
HDLC concentrations [23–26]. Such results were inde-
pendent of ethnicity, race, and many other relevant risk fac-
tors. Our results also align with known lipid trajectories
with biological aging; the Korean national data also showed
that the mean levels of all serum lipid levels in women in-
creased without upper threshold with aging, even exceeding
that of men after sixth decade [27]. Hitherto, current treat-
ment and surveillance guidelines highly advise precaution
for elevated lipid levels among middle-aged and elderly
women [19, 20, 28]. Furthermore, older adults were less
likely to correctly recognize target blood pressure and chol-
esterol levels, suggesting insufficient awareness of cardio-
vascular risks for punctual management [29]. These
findings highlight the need for improved promotion of
ASCVD prevention in elderly population segment.
However, the role of education is still debated. In earl-
ier Korean studies, only hypertriglyceridemia and
hypoalphalipoproteinemia were inversely associated with
education level in women [30]. Yet, a subsequent study
Table 2 Prevalence of dyslipidemia and its parameters by age and education level (n = 2049)
Age, year p-
value30–39 40–49 50–59 60–64
Low education level
Dyslipidemia 18 (22.5) 50 (27.2) 338 (48.2) 172 (61.4) < 0.0001
Hypercholesterolemia 3 (3.8) 15 (8.2) 111 (15.8) 33 (11.8) 0.001
Hypertriglyceridemia 11 (13.8) 20 (10.9) 150 (21.4) 75 (26.8) 0.0004
Hypoalphalipoproteinemia 4 (5.0) 5 (2.7) 34 (4.9) 16 (5.7) 0.4512
Hyper-LDL-cholesterolemia 2 (2.5) 10 (5.4) 73 (10.4) 16 (5.7) 0.007
High education level
Dyslipidemia 21 (9.0) 35 (19.2) 131 (44.4) 57 (60.6) < 0.0001
Hypercholesterolemia 4 (1.7) 11 (6.0) 55 (18.6) 14 (14.9) < 0.0001
Hypertriglyceridemia 11 (4.7) 19 (10.4) 60 (20.3) 20 (21.3) < 0.0001
Hypoalphalipoproteinemia 5 (2.2) 3 (1.7) 12 (4.1) 5 (5.3) 0.2204
Hyper-LDL-cholesterolemia 5 (2.2) 8 (4.4) 34 (11.5) 12 (12.8) < 0.0001
Values are presented as number (%)
P-value was derived from the analysis of variance test for multiple comparisons
Low education level refers to completion of high school or below; high education level refers to completion of
college or above
Abbreviation: LDL Low-density lipoprotein
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demonstrated that all parameters of dyslipidemia are
negatively associated with education level [13]. Inconsist-
encies are also observed in other nations’ studies. A
Swiss study reported that lower levels of education were
associated with high LDLC and TG levels in women
[31]. South Asian studies showed that despite abnormal
HDLC and LDLC were associated with increasing age,
no concrete association was found with education level,
occupation, and income category [26, 32]. Overview of
multinational surveys conducted in clinic/population,
urban/rural settings, low−/high-income, and middle-
aged/elderly populations indicated wide-ranging (15–
92%) hypoalphaliproteinemia prevalence [33]. In short,
education level appears to assume multifaceted role in
diverse ethnic, racial, and social frames.
The exact mechanisms underpinning the disproportion-
ate role of education on dyslipidemia remain unclear. One
possible explanation is that the interaction between un-
healthy lifestyle and increased psychosocial stress activate
inflammatory mediators, resulting in deleterious cardiovas-
cular pathology [34]. People with low SES are more prone
to unhealthy behaviors such as cigarette smoking, alcohol
drinking, physical inactivity, and unbalanced diet [34, 35].
Although the prevalence of cigarette smoking is low in Ko-
rean population [36], relatively higher proportion of
current smokers among our study participants in low edu-
cation group may mediate the presence of significant inter-
action for hypercholesterolemia. Moreover, whereas higher
education level is known to be associated with increased
physical activity, high-caloric and low-nutrient food
Fig. 2 a. Prevalence of hypercholesterolemia by age group and education level (n = 2049). Low education level refers to completion of high
school or below; high education level refers to completion of college or above. b. Prevalence of hypertriglyceridemia by age group and
education level (n = 2049). Low education level refers to completion of high school or below; high education level refers to completion of
college or above. c. Prevalence of hypoalphalipoproteinemia by age group and education level (n = 2049). Low education level refers to
completion of high school or below; high education level refers to completion of college or above. d. Prevalence of hyper-LDL-cholesterolemia
by age group and education level (n = 2049). Low education level refers to completion of high school or below; high education level refers to
completion of college or above
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consumption is more frequently observed in women of
lower level education [37, 38]. Such unfavorable health be-
haviors are known to induce psychosocial stress, thereby
accelerating atherosclerotic process and succession. It has
been suggested that persons of lower SES deploy less ef-
fective coping strategies and face more obstacles in acces-
sing larger support networks, greater material resources,
and healthcare to deal with stressful circumstances [39].
Moreover, slower recovery in cardiovascular responses
after acute stress in persons of lower SES may contribute
to atherosclerotic exacerbation [40]. Altogether, these can
hinder appropriate lipid management. In sum, if unhealthy
lifestyle attributable to low education level had contributed
to each serum lipid differentially, such would explain sig-
nificant age-education interaction observed only for high
TC and LDLC levels in our findings.
Another explanation is given that different SES indica-
tors operate in subtly different ways, their relationship
with dyslipidemia may vary according to the index being
used. A prospective Indian study showed that the preva-
lence of hypercholesterolemia and hypertriglyceridemia
increased significantly in the lower income group, but
observed no significant association with education level
[41]. Therefore, different SES indicators may exert cir-
cumstantial effects in different populations.
Perhaps individual unit of SES is cannot adequately cap-
ture the risk associated with dyslipidemia. Ecologic studies
have shown that people living in socioeconomically disad-
vantaged areas generally experience worse health outcomes
than do those living in more affluent areas, independent of
individual economic standing [42]. For instance, TG, but
not HDLC, levels were higher in participants with greater
neighborhood socioeconomic disadvantage than they were
in those with less neighborhood socioeconomic disadvan-
tage [43]. In a meta-analysis of African countries, the
overall prevalence of elevated TC was determined by the
geographic environment of residence, rather than individual
education level [44]. Structural environment may more
comprehensively capture the risk factors of dyslipidemia,
such as deprivation, poorer access to health care, and lack
of social support [45].
Divergent findings may reflect differences in methodo-
logical approaches. A longitudinal study that used in-
verse probability-weighted marginal structural model to
estimate the controlled direct effect of adult SES on
mortality, not mediated by health behaviors (accounting
for potential confounding by time-varying health status),
has confirmed the independent effect of SES [46]. Per-
haps prospective study design examining the incidence,
not prevalence, of dyslipidemia may better elucidate the
true effect of education level. Additionally, simultaneous
inclusion of multiple SES indicators in the same models
estimating the effects of education generates an ambigu-
ous causal parameter [46]. Statistical frameworks and
adjustments may determine education effect calculation
on clinical outcomes.
The strength of the study lies in its design and objective
to collect diverse and in-depth information on traditional
and emerging risk factors and biomarkers of cardiometa-
bolic disorders, which manifests through adverse lipid pro-
file. Moreover, the study population embodies diverse SES
and physiological background of community-dwelling,
middle-aged women, thereby strengthening external valid-
ity to the general Korean population. Many covariates, es-
pecially reproductive history, which is regarded as an
independent risk factor of dyslipidemia, was measured at
extensive depth and detail. Many studies have demon-
strated profound effect of menopause and hormone-
regulating medications on lipid concentrations [47, 48] our
results remained robust after adjusting for numerous
Fig. 3 Association between and age dyslipidemia parameters according to education level using a generalized linear model (n = 2049).
Abbreviation: LDL, low-density lipoprotein
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possible pathways that may otherwise distort the associ-
ation. Lastly, our results remained consistent even after
substituting the current primary prevention criteria with
more conservative treatment goal cutoff values recom-
mended by multinational guidelines. This may extend the
modifiability of education level on the association between
age and lipid levels, even at subclinical levels.
However, there are limitations to be considered. First,
the cross-sectional nature of our study only enabled us
to consider SES indicators and health behaviors as time-
fixed variables. However, adjusting for these covariates
measured at one point in time (in our case, adulthood)
may distort the lifetime contribution of education level
to dyslipidemia. Study has shown that the early-life SES
also have independent or mediating effects on adult-
onset of chronic diseases and mortality [49]. Another
concern is the absence of information regarding predis-
posed and non-modifiable risk factors. There is a grow-
ing body of evidence that combinations of multiple
genes harboring predisposing alleles have causal role to
the population variance of lipid levels [50–52]. Com-
bined with the single nucleotide polymorphisms,
behavioral-environmental interactions affect cholesterols
[2]. However, our study lacked information on familial
lipid abnormality nor population-specific SNP assay;
thus, hereditary information could not be adjusted for.
Furthermore, because single-occasion serum lipid mea-
surements were used to classify dyslipidemia, measure-
ment variability cannot be ruled out. Lastly, because
demographic information and the use of lipid-lowering
medications were obtained via self-report, response bias
cannot be ruled out.
Conclusion
The current study investigated the differential role of edu-
cation level on the association between age and individual
parameter of dyslipidemia in community-dwelling,
middle-aged women. While education level is difficult to
modify in middle-aged population, tailored lifestyle modi-
fication education programs can be implemented to raise
dyslipidemia awareness and control across all age groups.
Considering that elevated lipid levels are highly reversible
even with sustained healthy lifestyle, timely intervention
may deter the atherosclerotic process, thereby conserving
substantial healthcare burden at both individual and na-
tional level. Meanwhile, future studies are warranted to
further elucidate the role of education level on lipid pro-
files even across young and elderly populations, whom we
expect heterogeneous educational background. Alternative
features, such as the length of exposure to dyslipidemia,
genetic and biological susceptibility, or lipoprotein sub-
fractions, may supplement our current understandings on
this complex interplay.
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